Scalable production of iPSC-derived human neurons to identify tau-lowering compounds by high-content screening

Authors

Chao Wang, University of California, San Francisco
Michael E. Ward, University of California, San Francisco
Robert Chen, University of California, San Francisco
Kai Liu, University of California, San Francisco
Tara E. Tracy, University of California, San Francisco
Xu Chen, University of California, San Francisco
Min Xie, University of California, San Francisco
Peter Dongmin Sohn, University of California, San Francisco
Connor Ludwig, University of California, San Francisco
Anke Meyer-Franke, Gladstone Institute of Neurological Disease
Celeste M. Karch, Washington University School of Medicine in St. Louis
Sheng Ding, University of California, San Francisco
Li Gan, University of California, San Francisco

Journal

Stem Cell Reports

Publication Date

2017

Volume

9

Inclusive Pages

1221-1233

Document Type

Open Access Publication

DOI

10.1016/j.stemcr.2017.08.019

Rights and Permissions

Wang C, Ward ME, Chen R, et al (2017) Scalable Production of iPSC-Derived Human Neurons to Identify Tau-Lowering Compounds by High-Content Screening. Stem Cell Reports, 9:1221-1233. https://doi.org/10.1016/j.stemcr.2017.08.019 Copyright 2017 The Author(s). This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Recommended Citation

Wang, Chao; Ward, Michael E.; Chen, Robert; Liu, Kai; Tracy, Tara E.; Chen, Xu; Xie, Min; Sohn, Peter Dongmin; Ludwig, Connor; Meyer-Franke, Anke; Karch, Celeste M.; Ding, Sheng; and Gan, Li, "Scalable production of iPSC-derived human neurons to identify tau-lowering compounds by high-content screening." Stem Cell Reports. 9, 1221-1233. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/6249